Meeting
2024 ASCO Genitourinary Cancers Symposium
Circulating tumor DNA in the surveillance of patients with oligometastatic renal cell carcinoma treated with stereotactic ablative radiation.
Authors
Young Suk Suk Kwon
Department of Radiation Oncology, University of Texas Southwestern Medical Center, Dallas, TX
Young Suk Suk Kwon , Laurentiu Pop , Maggie Janell Stein , Alana Christie , Subrata Manna , Aurelie Garant , Daniel X. Yang , Neil B Desai , James Brugarolas , Robert D. Timmerman , Raquibul Hannan
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session C: Renal Cell Cancer; Adrenal, Penile, and Testicular Cancers
Track
Renal Cell Cancer,Adrenal Cancer,Penile Cancer,Testicular Cancer
Sub Track
Translational Research, Tumor Biology, Biomarkers, and Pathology
Citation
J Clin Oncol 42, 2024 (suppl 4; abstr 477)
DOI
10.1200/JCO.2024.42.4_suppl.477
Abstract #
477
Poster Bd #
K18
Abstract Disclosures
Similar Posters
Poster
2022 ASCO Annual Meeting
Prostate-specific membrane antigen PET response associates with radiographic progression-free survival following stereotactic ablative radiation therapy in oligometastatic castration-sensitive prostate cancer.
First Author: Philip Sutera
Poster
2021 Genitourinary Cancers Symposium
Phase II trial of stereotactic ablative radiation (SAbR) for oligometastatic kidney cancer.
First Author: Raquibul Hannan
Poster
2020 Genitourinary Cancers Symposium
A phase II randomized trial of Observation versus stereotactic ablative RadiatIon for OLigometastatic prostate CancEr (ORIOLE).
First Author: Phuoc T. Tran
Poster
2019 Genitourinary Cancers Symposium
Outcomes of stereotactic ablative radiotherapy for extra-cranial oligo-metastatic renal cell cancer.
First Author: Yuanyuan Zhang